TY - JOUR T1 - Symptom-based ordinal scale fuzzy clustering of functional gastrointestinal disorders JF - medRxiv DO - 10.1101/2020.05.11.20098376 SP - 2020.05.11.20098376 AU - Marjan Mansoruian AU - Hamid Reza Marateb AU - Ammar Hassanzadeh Keshteli AU - Hamed Daghagh Zadeh AU - Miquel Angel Mañanas AU - Peyman Adibi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098376.abstract N2 - Background The validity of Rome III criteria for diagnosing functional gastrointestinal disorders (FGIDs) have been frequently questioned in the literature. In epidemiology, when a disease is diagnosed, the existence of a true cluster must be proven. Thus, clustering the common GI symptoms of individuals and comparing the clusters with FGIDs defined by the Rome III criteria could provide insights about the validity of FGIDs defined by those criteria. Well-separated compact clusters were detected in responses to questionnaires of the epidemiological features of different FGIDs in Iranian adults using fuzzy ordinal clustering. The representative sample from each cluster i.e. Cluster Representative (CR) was formed whose corresponding FGID was diagnosed with Rome III criteria. Then, FGID diagnosis was performed for all participants in each cluster and the percentage of cases whose FGID was the same as the cluster’s identified FGID (agreement) was reported.Results Fourteen valid clusters were detected in 4763 people. The average membership of the objects in each cluster was 77.3%, indicating similarity of the objects in clusters to their corresponding CRs. Eight clusters were assigned to single FGIDs (irritable bowel syndromes: constipation IBS-C, diarrhea IBS-D and un-subtyped IBS-U; functional bloating FB; functional constipation FC; belching disorder BD. The agreement was higher than 50% in single FGID clusters except those whose diagnosis was IBS-U.Conclusions IBS-C, IBS-D, FC, BD, and FB defined with Rome III criteria exist in the population, which is not the case for IBS-U.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research leading to these results has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 712949 (TECNIOspring PLUS) and from the Agency for Business Competitiveness of the Government of Catalonia and also by the Spanish Ministry of Economy and Competitiveness- Spain project DPI2017-83989-R.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analyzed during the current study are not publicly available due to the institution limitations.BDbelching disorderCRCluster RepresentativeFGIDsfunctional gastrointestinal disordersFBfunctional bloatingFCfunctional constipationIBSirritable bowel syndromesIBSirritable bowel syndromeIBS-Cconstipation predominant IBSIBS-Ddiarrhea predominant IBSIBS-Uunsubtyped IBSPDSpostprandial distress syndromeSEPAHANStudy on the Epidemiology of Psychological, Alimentary Health and NutritionUHuninvestigated heartburn ER -